🇺🇸 FDA
Pipeline program

Kreon 35 000 Ph. Eur. Lipase Einheiten, magensaftresistente Hartkapseln

PANC-CAP-3001

Phase 3 small_molecule active

Quick answer

Kreon 35 000 Ph. Eur. Lipase Einheiten, magensaftresistente Hartkapseln for Male and female patients aged ≥ 18 to ≤ 85 years with a total pancreatectomy with Pancreatic Exocrine Insufficiency (PEI). is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Male and female patients aged ≥ 18 to ≤ 85 years with a total pancreatectomy with Pancreatic Exocrine Insufficiency (PEI).
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials